Experienced in Primary Amyloidosis

Liye Zhong

Key Laboratory For Regenerative Medicine Of Ministry Of Education, 
Guangzhou, CN 
Clinical Trials:Currently Recruiting for 1 Trial
Experienced in Primary Amyloidosis
Key Laboratory For Regenerative Medicine Of Ministry Of Education, 
Guangzhou, CN 
OverviewLocationsClinical Research

Overview

Liye Zhong practices in Guangzhou, China. Zhong is rated as an Experienced expert by MediFind in the treatment of Primary Amyloidosis. Their top areas of expertise are Primary Amyloidosis, Diffuse Large B-Cell Lymphoma (DLBCL), B-Cell Lymphoma, and Multiple Myeloma.

Their clinical research consists of co-authoring 25 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 7 articles in the study of Primary Amyloidosis.

Locations

Key Laboratory For Regenerative Medicine Of Ministry Of Education, Guangzhou, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Single-arm, Pivotal Registration Phase II Study of the Efficacy and Safety of APG-2575 Monotherapy in Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
A Single-arm, Pivotal Registration Phase II Study of the Efficacy and Safety of APG-2575 Monotherapy in Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Enrollment Status: Recruiting
Publish Date: January 23, 2024
Intervention Type: Drug
Study Drug: APG2575
Study Phase: Phase 2

25 Total Publications

High expression of CCL3/CCL4/CCL5/CCR5 promotes exhausted CD8+ T cells terminal differentiation and is associated with poor prognosis in pediatric B-ALL patients.
High expression of CCL3/CCL4/CCL5/CCR5 promotes exhausted CD8+ T cells terminal differentiation and is associated with poor prognosis in pediatric B-ALL patients.
Journal: International journal of immunopathology and pharmacology
Published: June 16, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Zhong's expertise for a condition
ConditionClose
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile